Diagnostic screening programs help catch cancer, abnormalities or other diseases before they reach an advanced stage, saving lives and healthcare costs. Screening programs include, lung, breast, prostate, and cervical cancer, among many others.
In conjunction with prevention efforts, the introduction of screening examinations has resulted in a reduction of nearly 6 million cancer-related deaths since 1975.
Breast density is most often discussed within the context of cancer risk, but new research suggests that it also could be used as a marker of cardiometabolic health.
The newly cleared offering, AutoChamber, was designed with opportunistic screening in mind. It can evaluate many different kinds of CT images, including those originally gathered to screen patients for lung cancer.
The Healthcare Information and Management Systems Society (HIMSS) this week signed an asset purchase agreement to acquire The Dorenfest IHDS+ Database and related business assets from Sheldon I. Dorenfest & Associates Ltd., a Chicago-based provider of hea
Analogic Corp. says that its decrease in revenue from last year "is about as expected" in response to its sales and earnings in the third fiscal quarter of FY04, ending April 30.
Sixty-six percent of U.S. healthcare providers are expected to increase their information technology budgets by at least 10 percent between now and 2006.
CAD developer R2 Technology Inc. this week appointed William J. Mercer as interim president and CEO, succeeding Michael Klein who resigned late last week.
DOBI Medical International Inc. this week reached agreement with the Food and Drug Administration (FDA) to conduct a multi-site clinical trial on its ComfortScan imaging system.
RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.
Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.
A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.
